- Patent Title: Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
-
Application No.: US16849957Application Date: 2020-04-15
-
Publication No.: US11298365B2Publication Date: 2022-04-12
- Inventor: Mahesh V. Patel , Nachiappan Chidambaram , Satish Kumar Nachaegari , Srinivasan Venkateshwaran , Joel Frank
- Applicant: Lipocine Inc.
- Applicant Address: US UT Salt Lake City
- Assignee: Lipocine Inc.
- Current Assignee: Lipocine Inc.
- Current Assignee Address: US UT Salt Lake City
- Agency: Thorpe North and Western, LLP
- Agent Michael R. Schramm; David W. Osborne
- Main IPC: A61K31/568
- IPC: A61K31/568 ; A61K39/00 ; A61K9/00 ; A61K9/16
Abstract:
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.
Public/Granted literature
- US20210069211A1 BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS Public/Granted day:2021-03-11
Information query
